236 related articles for article (PubMed ID: 15487757)
1. Role of copper in tumour angiogenesis--clinical implications.
Nasulewicz A; Mazur A; Opolski A
J Trace Elem Med Biol; 2004; 18(1):1-8. PubMed ID: 15487757
[TBL] [Abstract][Full Text] [Related]
2. [The role of copper in tumor angiogenesis--clinical implications].
Nasulewicz A; Opolski A
Postepy Hig Med Dosw; 2002; 56(6):691-705. PubMed ID: 12661402
[TBL] [Abstract][Full Text] [Related]
3. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
4. [Neoplasms and angiogenesis].
Lewy-Trenda I
Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
6. The role of angiogenesis in solid tumours: an overview.
Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K
Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
[TBL] [Abstract][Full Text] [Related]
7. [The clinical perspective of angiogenesis inhibitors].
Radema SA; Witteveen PO; Gebbink MB; Voest EE
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
[TBL] [Abstract][Full Text] [Related]
8. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
[TBL] [Abstract][Full Text] [Related]
9. Use of angiogenesis inhibitors in tumour treatment.
Fayette J; Soria JC; Armand JP
Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233
[TBL] [Abstract][Full Text] [Related]
10. Are tumours angiogenesis-dependent?
Verheul HM; Voest EE; Schlingemann RO
J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
[TBL] [Abstract][Full Text] [Related]
11. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
Brewer GJ; Merajver SD
Integr Cancer Ther; 2002 Dec; 1(4):327-37. PubMed ID: 14664727
[TBL] [Abstract][Full Text] [Related]
12. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
van Kempen LC; Leenders WP
Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
[TBL] [Abstract][Full Text] [Related]
13. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
Plavetić ND; Letilović T; Vrbanec D
Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
[TBL] [Abstract][Full Text] [Related]
14. Tumour vasculature as a target for anticancer therapy.
Eatock MM; Schätzlein A; Kaye SB
Cancer Treat Rev; 2000 Jun; 26(3):191-204. PubMed ID: 10814561
[TBL] [Abstract][Full Text] [Related]
15. Tumoral angiogenesis: review of the literature.
Khosravi Shahi P; Fernández Pineda I
Cancer Invest; 2008 Feb; 26(1):104-8. PubMed ID: 18181052
[TBL] [Abstract][Full Text] [Related]
16. [Targeting angiogenesis in oncology].
Fayette J; Soria JC; Armand JP
Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
18. The clinical implications of angiogenesis in the treatment of cancer.
Aoun E; Taher A
J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis modulation in cancer research: novel clinical approaches.
Cristofanilli M; Charnsangavej C; Hortobagyi GN
Nat Rev Drug Discov; 2002 Jun; 1(6):415-26. PubMed ID: 12119743
[TBL] [Abstract][Full Text] [Related]
20. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]